Atomwise

Atomwise company information, Employees & Contact Information

Explore related pages

Related company profiles:

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers

Company Details

Employees
35
Founded
-
Address
717 Market St.,
Email
he****@****ise.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Francisco, California
Looking for a particular Atomwise employee's phone or email?

Atomwise Questions

News

UK's Korotkov Partners With Atomwise to Screen for Potential Drugs Against Novel COVID-19 Target - UKNow

UK's Korotkov Partners With Atomwise to Screen for Potential Drugs Against Novel COVID-19 Target UKNow

Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority - Business Wire

Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority Business Wire

With AI we can move into uncharted territory for drug discovery and solve the impossible targets - statnews.com

With AI we can move into uncharted territory for drug discovery and solve the impossible targets statnews.com

Atomwise and Sanofi partner for drug discovery using AI - Pharmaceutical Technology

Atomwise and Sanofi partner for drug discovery using AI Pharmaceutical Technology

AI-based drug discovery with Atomwise and WEKA Data Platform - Amazon Web Services

AI-based drug discovery with Atomwise and WEKA Data Platform Amazon Web Services

Sanofi signs $1.2B pact with Atomwise in latest high-value AI drug discovery deal - Fierce Biotech

Sanofi signs $1.2B pact with Atomwise in latest high-value AI drug discovery deal Fierce Biotech

Flipping the Script: Atomwise AI Platform Presents an Alternative to High Throughput Screening - Genetic Engineering and Biotechnology News

Flipping the Script: Atomwise AI Platform Presents an Alternative to High Throughput Screening Genetic Engineering and Biotechnology News

Scoop: Founding CEO leaves Atomwise, casting doubt over a once high-flying AI startup - Endpoints News

Scoop: Founding CEO leaves Atomwise, casting doubt over a once high-flying AI startup Endpoints News

Atomwise's AI-driven drug screening heralds a generational shift - drugdiscoverytrends.com

Atomwise's AI-driven drug screening heralds a generational shift drugdiscoverytrends.com

Atomwise Raises $123 Million to Accelerate AI Drug Discovery - NVIDIA Developer

Atomwise Raises $123 Million to Accelerate AI Drug Discovery NVIDIA Developer

Atomwise Enters Three Joint Ventures to Use AI Platform for Drug Development - BioSpace

Atomwise Enters Three Joint Ventures to Use AI Platform for Drug Development BioSpace

Atomwise Publishes Results from 318-Target Study Showcasing AtomNet AI Platform’s Ability to Discover Structurally Novel Chemical Matter - Business Wire

Atomwise Publishes Results from 318-Target Study Showcasing AtomNet AI Platform’s Ability to Discover Structurally Novel Chemical Matter Business Wire

Exclusive: 'Faster isn't better' — Atomwise moves from partnerships to pipeline with TYK2 drug - Endpoints News

Exclusive: 'Faster isn't better' — Atomwise moves from partnerships to pipeline with TYK2 drug Endpoints News

AI drug prospector Atomwise to screen 10B compounds for potential childhood cancer therapies - Fierce Biotech

AI drug prospector Atomwise to screen 10B compounds for potential childhood cancer therapies Fierce Biotech

Hansoh Expands AI Partnership with Atomwise after Early Success for Key Target in Therapy-Evading Cancers - Business Wire

Hansoh Expands AI Partnership with Atomwise after Early Success for Key Target in Therapy-Evading Cancers Business Wire

Atomwise, FutuRx launch new AI-powered immuno-oncology biotech - Fierce Biotech

Atomwise, FutuRx launch new AI-powered immuno-oncology biotech Fierce Biotech

Bridge Biotherapeutics Enters AI-based Research Collaboration with Atomwise to Expand Pellino Inhibitor Pipeline - Business Wire

Bridge Biotherapeutics Enters AI-based Research Collaboration with Atomwise to Expand Pellino Inhibitor Pipeline Business Wire

Atomwise, Bridge Biotherapeutics pen $1B deal for AI-devised molecules - Fierce Biotech

Atomwise, Bridge Biotherapeutics pen $1B deal for AI-devised molecules Fierce Biotech

Atomwise Announces Nomination of its First AI-Driven Development Candidate Focused on TYK2 Inhibition and Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer - Business Wire

Atomwise Announces Nomination of its First AI-Driven Development Candidate Focused on TYK2 Inhibition and Appoints Neely Mozaffarian, MD, PhD as Chief Medical Officer Business Wire

Charles River and AI specialist Atomwise team on drug discovery - Fierce Biotech

Charles River and AI specialist Atomwise team on drug discovery Fierce Biotech

Atomwise Announces Largest China-US Collaboration for AI Drug Discovery - us.acrofan.com

Atomwise Announces Largest China-US Collaboration for AI Drug Discovery us.acrofan.com

Atomwise raises $123M to expand AI-powered drug design efforts - Fierce Biotech

Atomwise raises $123M to expand AI-powered drug design efforts Fierce Biotech

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market - Genetic Engineering and Biotechnology News

AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market Genetic Engineering and Biotechnology News

Atomwise takes on 2 more JVs, including a $1.5B project with China's Hansoh Pharma - Fierce Biotech

Atomwise takes on 2 more JVs, including a $1.5B project with China's Hansoh Pharma Fierce Biotech

Here's the pitch deck that AI-backed drug discovery startup Atomwise used to raise $123 million in Series B funding - businessinsider.com

Here's the pitch deck that AI-backed drug discovery startup Atomwise used to raise $123 million in Series B funding businessinsider.com

Exclusive: Atomwise, a once high-flying AI startup, taps biotech vet as CEO to lead pared-down company - Endpoints News

Exclusive: Atomwise, a once high-flying AI startup, taps biotech vet as CEO to lead pared-down company Endpoints News

Designing Better Drugs: Atomwise Lands $123M To Advance AI Drug Discovery - Crunchbase News

Designing Better Drugs: Atomwise Lands $123M To Advance AI Drug Discovery Crunchbase News

How Atomwise uses artificial intelligence for drug discovery - Technology Magazine

How Atomwise uses artificial intelligence for drug discovery Technology Magazine

AI Revolution in Life Sciences: Promises, Challenges and Patent Rights - Fasken

AI Revolution in Life Sciences: Promises, Challenges and Patent Rights Fasken

Eli Lilly to pay Atomwise $1M for each AI-discovered drug - Fierce Biotech

Eli Lilly to pay Atomwise $1M for each AI-discovered drug Fierce Biotech

AI-driven drug discovery startup Atomwise raises $45M series A - Fierce Biotech

AI-driven drug discovery startup Atomwise raises $45M series A Fierce Biotech

How an AI startup is disrupting pharma using convolutional neural networks. - Psychology Today

How an AI startup is disrupting pharma using convolutional neural networks. Psychology Today

New Atomwise offshoot X-37 raises $14.5M to shepherd AI-designed drugs - Fierce Biotech

New Atomwise offshoot X-37 raises $14.5M to shepherd AI-designed drugs Fierce Biotech

Atomwise, Hansoh Pharma Enter Into Up-to-$1.5B AI-Based Drug Discovery Partnership - Genetic Engineering and Biotechnology News

Atomwise, Hansoh Pharma Enter Into Up-to-$1.5B AI-Based Drug Discovery Partnership Genetic Engineering and Biotechnology News

Deep learning startup Atomwise raises $45M - TechCrunch

Deep learning startup Atomwise raises $45M TechCrunch

Atomwise's Abraham Heifets Uses AI to Speed the Development of Medications - Newsweek

Atomwise's Abraham Heifets Uses AI to Speed the Development of Medications Newsweek

San Francisco's Atomwise secures millions for AI-powered drug discovery - The Business Journals

San Francisco's Atomwise secures millions for AI-powered drug discovery The Business Journals

Atomwise Raises $45M for Artificial Intelligence Platform for Drug Discovery - HIT Consultant

Atomwise Raises $45M for Artificial Intelligence Platform for Drug Discovery HIT Consultant

Atomwise raises $163 million CAD Series B - BetaKit

Atomwise raises $163 million CAD Series B BetaKit

UM partners with artificial intelligence leader Atomwise to pursue COVID-19 therapies - UM Today News

UM partners with artificial intelligence leader Atomwise to pursue COVID-19 therapies UM Today News

Y Combinator demo-thon: Check out 5 favorites from Day 2 - The Business Journals

Y Combinator demo-thon: Check out 5 favorites from Day 2 The Business Journals

Top Atomwise Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant